World's Largest Resource for Cardiovascular Perfusion

Perfusion NewswireECMO ZoneCytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients

CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients

  • The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
  • Based on bench performance testing and reported clinical experience, the FDA concludes the CytoSorb device – also referred to as an Extracorporeal Blood Purification device – may be effective at treating certain patients with confirmed Covid-19 by removing various pro-inflammatory cytokines from their blood.
  • The FDA believes the removal of pro-inflammatory cytokines may ameliorate cytokine storm due to the overabundance of pro-inflammatory cytokines and thus provide clinical benefit.

Leave a Reply

#1 largest online community of Perfusionists

Join Our
Online Community

Get your swag kit by becoming a member or updating profile.
Swag will be sent to U.S. mailing addresses only.

©2023 Perfusion. All Rights Reserved. Privacy Policy